SPDR S&P Biotech ETF Rating $130.69 -4.16 (-3.08%) As of 05/15/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.75Holdings in XBI have an aggregate rating of Moderate Buy based on 400 analyst ratings issued in the past year covering 25 companies (33.7% of the portfolio).XBI Aggregate Price Target$130.69High Prediction$130.69Average Prediction$130.69Low Prediction$130.69Holdings in XBI have an aggregate price target of $130.69 and a range of $130.69 to $130.69 covering 25 companies (33.7% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XBI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.70%TGTXTG Therapeutics$39.50-3.2%4.0926 of 5 stars2.57$52.50 32.9%71.68%TVTXTravere Therapeutics$42.59-3.4%2.0768 of 5 stars2.69$47.83 12.3%131.68%RVMDRevolution Medicines$145.66-2.5%2.225 of 5 stars3.10$103.88 -28.7%201.57%ALKSAlkermes$37.48-2.3%2.4787 of 5 stars2.76$45.40 21.1%17Analyst ForecastAnalyst Revision1.50%ARWRArrowhead Pharmaceuticals$76.67-3.8%2.1908 of 5 stars2.83$87.80 14.5%12Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.39%NBIXNeurocrine Biosciences$158.42-0.4%3.7638 of 5 stars2.82$184.15 16.2%22Insider Trade1.37%EXELExelixis$50.13-1.9%2.7295 of 5 stars2.39$47.35 -5.5%23Positive News1.37%KRYSKrystal Biotech$306.29-3.2%2.6878 of 5 stars2.83$324.11 5.8%121.37%BEAMBeam Therapeutics$27.93-5.4%3.5193 of 5 stars2.71$46.83 67.7%14Trending NewsAnalyst ForecastAnalyst RevisionGap Down1.36%CYTKCytokinetics$75.85-3.5%2.8079 of 5 stars2.82$98.55 29.9%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision1.35%MDGLMadrigal Pharmaceuticals$523.69-3.0%3.1335 of 5 stars2.76$687.00 31.2%17Analyst ForecastAnalyst Revision1.33%MIRMMirum Pharmaceuticals$102.18-8.3%2.5391 of 5 stars2.93$136.42 33.5%14Analyst Revision1.31%PRAXPraxis Precision Medicines$342.58-0.9%3.3353 of 5 stars2.95$592.67 73.0%20Analyst ForecastAnalyst RevisionGap Down1.30%SRRKScholar Rock$49.35-3.8%2.4261 of 5 stars3.17$56.00 13.5%18Analyst Revision1.30%TWSTTwist Bioscience$49.17-7.1%2.5003 of 5 stars2.75$56.57 15.1%8Insider TradeGap Down1.26%APGEApogee Therapeutics$81.14-3.3%2.9283 of 5 stars2.78$112.73 38.9%18Earnings ReportInsider Trade1.25%CGONCG Oncology$66.93-3.8%2.4839 of 5 stars2.77$81.73 22.1%13Earnings ReportAnalyst ForecastAnalyst Revision1.25%PTCTPTC Therapeutics$71.47-1.7%3.4204 of 5 stars2.57$88.36 23.6%14Insider Trade1.21%SMMTSummit Therapeutics$16.87-7.0%2.9986 of 5 stars2.50$27.58 63.5%161.20%PTGXProtagonist Therapeutics$102.18-3.2%1.9009 of 5 stars2.80$113.69 11.3%15Insider Trade1.20%BIIBBiogen$192.95+0.8%3.684 of 5 stars2.52$215.62 11.7%29Trending NewsAnalyst Forecast1.20%CELCCelcuity$137.68+2.2%1.7688 of 5 stars2.75$140.20 1.8%12Trending NewsEarnings ReportAnalyst ForecastGap Down1.19%UTHRUnited Therapeutics$568.58-1.3%3.6802 of 5 stars2.85$619.42 8.9%13Trending NewsInsider TradeAnalyst Revision1.18%CRSPCRISPR Therapeutics$48.41-4.0%3.2143 of 5 stars2.53$65.47 35.2%19Analyst Forecast1.18%HALOHalozyme Therapeutics$67.12-3.0%4.1834 of 5 stars2.50$80.67 20.2%12Earnings ReportAnalyst ForecastInsider Trade This page (NYSEARCA:XBI) was last updated on 5/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX Goes Public. Here's What Happens To Your IRA.When SpaceX goes public, fund managers will sell existing portfolio holdings to fund the move. Trillions in as...Americas Gold Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBI Stock Alerts